Invention Grant
US07687532B2 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
失效
用于治疗IA的p38激酶抑制剂的稠合的杂芳基衍生物 类风湿关节炎
- Patent Title: Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
- Patent Title (中): 用于治疗IA的p38激酶抑制剂的稠合的杂芳基衍生物 类风湿关节炎
-
Application No.: US10587614Application Date: 2005-01-27
-
Publication No.: US07687532B2Publication Date: 2010-03-30
- Inventor: Sebastien Andre Campos , Stephen Swanson , Ann Louise Walker
- Applicant: Sebastien Andre Campos , Stephen Swanson , Ann Louise Walker
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithkline LLC
- Current Assignee: GlaxoSmithkline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Dara L. Dinner; Theodore R. Furman
- Priority: GB0402140.8 20040130
- International Application: PCT/GB2005/000281 WO 20050127
- International Announcement: WO2005/073219 WO 20050811
- Main IPC: C07D405/06
- IPC: C07D405/06 ; C07D413/06 ; C07D403/06 ; C07D401/06 ; A61K31/416 ; A61K31/5377 ; A61K31/496 ; A61K31/454
Abstract:
Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
Public/Granted literature
Information query
